Gastroenterology

Papers
(The H4-Index of Gastroenterology is 89. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
1042 MEDICATIONS AND RISK OF MICROSCOPIC COLITIS: A NATIONWIDE COHORT STUDY1025
560 SELECT AMINO ACIDS (AA-ORS) IMPROVE ELECTROLYTE AND FLUID ABSORPTION IN A RODENT DIARRHEA MODEL748
756 ELEVATED DIACYLGLYCEROL O-ACYLTRANSFERASES 1 AND 2 (DGAT1/2) REINFORCE A NEGATIVE REGULATORY LOOP OF LIPID DROPLETS AND FOXO3 TRANSCRIPTION FACTOR THAT DRIVES METABOLIC AND TUMEROGENIC REMODELING 505
1136 IMPROVED HEPATOCELLULAR CARCINOMA SURVEILLANCE WITH ANALYTICAL QUALITY IMPROVEMENT MEASURES, ELECTRONIC MEDICAL RECORD ALERTS COMBINED WITH PATIENT EDUCATION AND OUTREACH FOR PATIENTS WITH CIRRHO439
1123 LOSS OF INTESTINAL EPITHELIAL DUOX2 SIGNALING IS ACCOMPANIED BY A REDUCTION IN AKKERMANSIACEAE AND PROMOTES THE DEVELOPMENT OF METABOLIC SYNDROME IN A MICROBIOME-DEPENDENT MANNER.423
954 MESENCHYMAL STEM CELLS AMELIORATE INFLAMMATION IN AN EXPERIMENTAL MODEL OF CROHN'S DISEASE VIA THE MESENTERY311
1027 EFFICACY AND SAFETY OF INTRAVENOUS USTEKINUMAB REINDUCTION THERAPY IN CROHN'S DISEASE PATIENTS WITH SECONDARY LOSS OF RESPONSE TO USTEKINUMAB MAINTENANCE THERAPY: WEEK 16 RESULTS FROM THE POWER T280
140 FRAILTY IS ASSOCIATED WITH HIGHER IN-HOSPITAL MORTALITY, COMPLICATIONS AND HOSPITAL COST IN PATIENTS ADMITTED WITH DECOMPENSATED CIRRHOSIS: A NATIONWIDE STUDY.264
934 GERD-INDUCED ALTERATIONS IN HYDROGEN SULFIDE SIGNALING AS THE FUNDAMENTAL MECHANISM OF BARRETT'S ESOPHAGUS PATHOGENESIS264
478 NON-CANONICAL ACTIVIN A SIGNALING STIMULATES CONTEXTDEPENDENT AND CELLULAR-SPECIFIC OUTCOMES IN CRC TO PROMOTE TUMOR CELL MIGRATION AND TOLERANCE258
Sa1834 VISCERAL ADIPOSITY INDEPENDENTLY PREDICTS TIME TO FLARE IN INFLAMMATORY BOWEL DISEASE, BUT BMI DOES NOT257
Sa1829 TEMPORAL TRENDS IN 30-DAY AND 90-DAY HOSPITAL RE-ADMISSION RATES AMONG PERSONS WITH CROHN'S DISEASE IN THE POSTBIOLOGIC ERA: A POPULATION-BASED STUDY FROM A LARGE CANADIAN PROVINCE242
Sa1779 THE EPIDEMIOLOGY AND CHARACTERISTICS OF DE NOVO IBD AFTER SOLID ORGAN OR HEMATOPOIETIC STEM CELL TRANSPLANT BETWEEN 2011-2021: A LARGE POPOULATION-BASED STUDY234
224 EXTERNAL VALIDATION OF A DEEP LEARNING MODEL FOR WHOLE SLIDE IMAGE ANALYSIS IN THE HISTOLOGIC DIAGNOSIS OF DYSPLASTIC BARRETT'S ESOPHAGUS226
288 OPTICAL COHERENCE TOMOGRAPHY GUIDED LASER CAPTURING OF GASTROINTESTINAL TRACT TISSUE FOR GENOMIC ANALYSIS214
699 SAFETY OUTCOMES AND CONCOMITANT MEDICATION CHANGES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE BEING TREATED WITH RBX2660 FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION205
855 CAN CYTOSPONGE HELP TRIAGE PATIENTS WHO CAN BE DISCHARGED FROM BARRETT'S SURVEILLANCE PROGRAMMES? A 2-YEAR SINGLE SITE UK STUDY196
Su1807 IBD MEDICATION USE IN PREGNANCY IS ASSOCIATED WITH A LOW RATE OF CONGENITAL ANOMALIES IN NEONATES: RESULTS FROM AN ANALYSIS OF THE BRITISH COLUMBIA POPULATION DATABASE.194
Su1776 EARLY AND RAPID USTEKINUMAB ADOPTION FOR INFLAMMATORY BOWEL DISEASE TREATMENT194
Tu1103 CROSS-SECTIONAL VS. LONG-TERM ADHERENCE TO COLORECTAL SCREENING IN A LARGE VA COHORT190
Mo1532 ANTIVIRAL TREATMENT AND ITS RESPONSE REDUCE DEVELOPMENT OF DEMENTIA AMONG HEPATITIS C VIRUS INFECTED PATIENTS IN THE U.S.185
Tu1493 RISK FACTORS OF DEVELOPING NONALCOHOLIC FATTY LIVER DISEASE FOLLOWING PANCREATIC RESECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS180
Tu1924 FORGOTTEN BUT STILL RELEVANT: VITAMIN C DEFICIENCY IN CHILDREN WITH COMPLEX MEDICAL PROBLEMS180
Mo1501 A NOVEL PROGNOSTIC MODEL USING DONOR AND RECIPIENT CHARACTERISTICS TO PREDICT EARLY POST-TRANSPLANT MORTALITY IN PATIENTS WITH ACUTE LIVER FAILURE180
991 COST-EFFECTIVENESS OF RISK-STRATIFIED POST-HEPATECTOMY CARE PATHWAY IMPLEMENTATION179
Tu1525 ALL THE MORE PEOPLE TO SCREEN: A LASTING IMPACT OF A QUALITY IMPROVEMENT INITIATIVE TO INCREASE HEPATITIS C SCREENING IN AN UNDERINSURED POPULATION174
Sa1563 DEVELOPMENT AND VALIDATION OF A NOMOGRAM TO BETTER PREDICT SARCOPENIA IN NAFLD PATIENTS: AN INSIGHT FROM THE NHANES 2017-2018171
228 LAPAROSCOPIC DISTAL PANCREATECTOMY BY RADICAL ANTEGRADE MODULAR PANCREATOSPLENECTOMY (RAMPS)166
1097 PATIENTS ADMITTED WITH ACUTE CHOLECYSTITIS AND ASSOCIATED COVID 19 HAD LESS RATES OF SAME ADMISSION CHOLECYSTECTOMY BUT NOT INCREASED MORTALITY162
Su1598 IS THERE A ROLE FOR PRE-EMPTIVE TIPS IN ACUTE VARICEAL BLEEDING? REAL WORLD DATA FROM A LOCAL ASIAN COHORT158
530 COMPARISON OF OUTCOMES FOR PATIENTS UNDERGOING SADI VS. RYGB IN 2020 AND 2021156
Sa2007 INSURANCE DELAYS BIOLOGIC AND SMALL MOLECULE TREATMENT OF PEDIATRIC IBD IN TERTIARY CARE CENTER155
Sa1916 THE EFFECT OF TEDUGLUTIDE ON THE UTILIZATION OF ENTERAL NUTRIENTS FOR THE SYNTHESIS OF HEPATIC, PANCREATIC AND MUCOSAL PROTEINS IN PATIENTS WITH SHORT BOWEL SYNDROME153
Sa2001 GROWTH OUTCOMES OF IV ANTI-TNF BIOSIMILARS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE151
Sa1247 NEW INSIGHTS ON THE MECHANISM OF ACTION OF HYOSCINE BUTYLBROMIDE (HBB) IN THE HUMAN COLON: HBB MODULATES EFFECT OF NEURONAL AND NON-NEURONAL ACETYLCHOLINE145
Sa1244 BIOPHYSICAL PROPERTIES OF GASTROINTESTINAL SMOOTH MUSCLE CELL MECHANOGATED CHANNEL TMEM63A144
Spotlight141
Mo1129 PHASE 3 BIOMARKER STUDY FOR HCC SURVEILLANCE USING A NOVEL HES V2.0 ALGORITHM. A PROSPECTIVE COLLECTION WITH RETROSPECTIVE BLINDED EVALUATION139
Reply139
Elsewhere in the AGA Journals (Preview Section)138
Sa1024 THE IMPACT OF HOMELESSNESS ON ENDOSCOPY UTILIZATION, SURGICAL TREATMENT, AND POST-OPERATIVE COMPLICATIONS AMONG HOSPITALIZED PATIENTS WITH ULCERATIVE COLITIS137
Sa1015 RACIAL AND ETHNIC DISPARITIES IN COST-RELATED BARRIERS TO MEDICATION ADHERENCE AMONG PATIENTS WITH IBD ENROLLED IN THE NATIONAL INSTITUTES OF HEALTH ALL OF US RESEARCH PROGRAM137
Sa1094 PREVALENCE AND PREDICTORS OF COLONIC NEOPLASIA BY INDICATION AND AGE IN THE GIQUIC NATIONAL REGISTRY136
456 PRECONCEPTION GUT DYSBIOSIS AFFECTS ENTERIC NERVOUS SYSTEM DEVELOPMENT AND FUNCTION OF OFFSPRING IN MICE136
Sa1167 IMPACT OF ENDOSCOPIC FULL THICKNESS RESECTION ON THE PATHOLOGIC STAGING AND CLINICAL OUTCOMES OF NEUROENDOCRINE TUMORS IN THE DIGESTIVE TRACT136
Sa1827 PRE-COLECTOMY EXTRAINTESTINAL MANIFESTATIONS AND CROHN'S DISEASE LIKE POUCHITIS ARE SIGNIFICANTLY ASSOCIATED WITH THE DEVELOPMENT OF POST-ILEAL POUCH ANAL ANASTOMOSIS EXTRAINTESTINAL MANIFESTAT134
Sa1224 UPON EX VIVO EXPANSION INFLAMED INTESTINAL EPITHELIAL CELLS FROM ULCERATIVE COLITIS RESTORE A NON-INFLAMED TRANSCRIPTIONAL PROFILE131
Su1130 ASSOCIATION OF CARBOHYDRATE SULFOTRANSFERASE 15 AND PROGNOSIS IN UNRESECTABLE PANCREATIC CANCER TISSUE BIOPSIES BY ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION131
Tu1662 IRRITABLE BOWEL SYNDROME PATIENTS REPORT HIGHER SYMPTOM BURDEN IN END-OF-DAY VERSUS MOMENTARY ASSESSMENTS: RESULTS FROM A PSYCHOMETRIC VALIDATION STUDY124
Su1787 EFFECT OF UPADACITINIB ON LIPID PROFILES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: POOLED ANALYSIS OF PHASE 3 INDUCTION AND MAINTENANCE STUDIES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE124
1123 GOBLET CELL ADENOCARCINOMA AND RESPONSE TO TREATMENT - SINGLE CENTER EXPERIENCE OF A RARE MALIGNANCY123
Tu1442 EFFECT OF SKELETAL MUSCLE MASS LOSS ON OUTCOMES OF PATIENTS WITH INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS.123
Tu1764 HIGH DIMENSIONAL PROFILING OF IL-23-RESPONSIVE CELLS REVEALED MOLECULAR SIGNATURES THAT PREDICT RESPONSE TO ANTI-IL-23 THERAPY IN PATIENTS WITH CROHN'S DISEASE123
32 SIMPLE ENDOSCOPIC SCORE FOR CROHN'S DISEASE (SES-CD) ≥ 7 PREDICTS DISEASE PROGRESSION IN PATIENTS WITH MILD CD122
Mo1239 ANALYSIS OF CHARACTERISTICS AND MICROBIOTA OF GASTRIC CANCER OCCURRING IN HIGH-RISK COUNTRIES120
Su1421 LONG-TERM PROGNOSIS INCLUDING CANCER DEVELOPMENT IN PATIENTS WITH CHRONIC PANCREATITIS: A MULTICENTER COHORT STUDY IN JAPAN118
1222 THE ASSOCIATION OF SOCIAL VULNERABILITY INDEX AND COLORECTAL CANCER SCREENING RATE IN THE US116
337 ANCESTRY-SPECIFIC GENETIC EFFECTS IDENTIFIED IN A COHORT OF HISPANICS WITH INFLAMMATORY BOWEL DISEASE115
Sa1926 WASHED MICROBIOTA TRANSPLANTATION FOR REFRACTORY INTESTINAL INFECTIONS: FINDINGS FROM A NATIONAL MUTI-CENTER, REAL-WORLD STUDY112
Mo1663 TRANSFORMING DIABETIC GASTROPARESIS CARE IN WOMEN: INSIGHTS FROM NASAL METOCLOPRAMIDE USAGE112
Sa1727 IMPLICATIONS OF SHAME FOR PATIENT REPORTED OUTCOMES IN FUNCTIONAL BOWEL DISORDERS111
Su1240 P2X4 BLOCKADE AS A NEW THERAPEUTICAL STRATEGY TO RELIEVE VISCERAL PAIN IN A RAT MODEL OF COLITIS109
Tu1770 DISEASE DURATION IMPACTS INTESTINAL GENE EXPRESSION PROFILES IN CROHN'S DISEASE BUT NOT IN ULCERATIVE COLITIS108
Su1145 PRIMARY SQUAMOUS CELL CARCINOMA OF THE GALLBLADDER IS EXTREMELY RARE AND ASSOCIATED WITH POOR SURVIVAL107
Tu1954 INSULIN AND AMPK-MEDIATED ALTERATIONS IN DNA METHYLATION: IMPLICATIONS FOR OBESITY-ASSOCIATED COLORECTAL CANCER107
981 WESTERN DIET DEPLETES SMALL INTESTINAL INTRAEPITHELIAL LYMPHOCYTES VIA FXR-TYPE I INTERFERON PATHWAY106
Sa1823 DEVELOPMENT AND INTERNAL-EXTERNAL VALIDATION OF A DYNAMIC MULTIVARIABLE PREDICTION MODEL FOR ADVANCED COLORECTAL NEOPLASIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE106
702 MAGNESIUM IS THE MAJOR ACTIVATOR OF CALCIUM-SENSING RECEPTOR IN THE INTESTINE AND ITS SUPPLEMENTATION CAN TREAT SECRETORY DIARRHEA105
765 RISK STRATIFICATION IN FIT-BASED COLORECTAL CANCER SCREENING: INTERVAL CANCER RISK AFTER THE UPPER AGE LIMIT OF SCREENING HAS BEEN REACHED104
868 DISSECTING GUT-BRAIN AXIS: ALTERED MULTI-KINGDOM GUT MICROBIOME IN AUTISM SPECTRUM DISORDER102
758 BHLHE40 IN GROUP 3 INNATE LYMPHOID CELLS SHAPES TL1ADEPENDENT COMMENSAL T CELL IMMUNITY102
658 WOUND HEALING AFTER EPISIOTOMY AND CESAREAN SECTION AMONG WOMEN WITH IBD100
1162 TRANSCUTANEOUS AURICULAR VAGAL NERVE STIMULATION IMPROVES FUNCTIONAL DYSPEPSIA WITH SLEEP DISTURBANCE VIA ENHANCED VAGAL ACTIVITY99
1268 COMBINED BODY SURFACE GASTRIC MAPPING AND GASTRIC EMPTYING TESTING REVEALS DISTINCT PATIENT SUBGROUPS IN GASTROPARESIS99
1169 CLINICAL UTILITY OF NEXT-GENERATION SEQUENCING FOR DIFFERENTIATING MAIN-DUCT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM AND CHRONIC PANCREATITIS AS ETIOLOGY OF PANCREATIC DUCT DILATION98
1282 EFFICACY OF STRUCTURAL INDIVIDUAL LOW FODMAP DIETARY ADVICE (SILFD) FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD) : A RANDOMIZED TRIAL96
1163 A NOVEL CLINICAL CLASSIFICATION SCHEME FOR GASTRIC ALIMETRY TESTING IN GASTRODUODENAL DISORDERS96
Su1809 ASSESSMENT OF STEROID USE IN PATIENTS WITH ACTIVE ULCERATIVE COLITIS WHO INITIATED A NEW JANUS KINASE INHIBITOR OR TUMOR NECROSIS FACTOR INHIBITOR USING DATA FROM A UNITED STATES CLAIMS DATABAS95
1160 THE INTERPLAY BETWEEN DIET AND THE GUT MICROBIOME IN DETERMINING PLASMA C-REACTIVE PROTEIN LEVELS IN HEALTHY INDIVIDUALS95
Su1220 IDENTIFICATION OF A LOOSELY COUPLED REGION IN THE DISTAL RAT STOMACH AND ANTRAL RESPONSE TO CERVICAL VAGUS NERVE STIMULATION, DEFINED BY HIGH-RESOLUTION BIOELECTRICAL MAPPING94
836 THE USE OF SLEEVE GASTRECTOMY FOR ELDERLY AND FRAIL OBESE PATIENTS IS SAFE, AND IT RESOLVES THEIR COMORBIDITIES IN MOST CASES94
95 VALIDATION OF RISK ASSESSMENT TOOLS FOR THE DETECTION OF BARRETT'S ESOPHAGUS IN PATIENTS WITHOUT CHRONIC REFLUX SYMPTOMS94
Su1254 EPIDEMIOLOGY AND CHARACTERISTICS OF BARRETT'S ESOPHAGUS IN PATIENTS WITH AND WITHOUT GERD: A LARGE US POPULATION STUDY93
Sa1546 ALARMING TRENDS IN ALCOHOLIC LIVER DISEASE RELATED MORTALITY AMONG AMERICAN INDIANS IN THE UNITED STATES FROM 1999-202092
Mo1022 ELECTRONIC CODING FOR ABNORMAL FECAL IMMUNOCHEMICAL TEST IS ASSOCIATED WITH INCREASED COLONOSCOPY COMPLETION90
Su1444 ACTIVIN A SIGNALING STIMULATES INNATE IMMUNE CELL ACTIVATION IN PANCREATITIS90
Su1436 POOLED CLINICAL OUTCOMES OF PANCREATITIS INDUCED SPLENIC VEIN THROMBOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS90
Su1697 ROBOTIC COLORECTAL RESECTIONS ARE ASSOCIATED WITH LESS POSTOPERATIVE PAIN AND REDUCED POSTOPERATIVE OPIOID USE COMPARED TO THE LAPAROSCOPIC APPROACH90
Tu1534 MULTICENTER COMPARISON OF ABBREVIATED MRI VERSUS ULTRASOUND FOR DETECTING EARLY-STAGE HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CIRRHOSIS89
Mo1190 INVESTIGATING THE NEED FOR ADJUSTING OMEPRAZOLE DOSAGE AND TIMING POST-BARIATRIC SURGERY: A META-ANALYTICAL APPROACH89
EP32 BISPECIFIC NANOBODY ENHANCES THE IMMUNE RESPONSE TO ANTIPD-L1 IN COLORECTAL CANCER BY BLOCKING CCL5/CCR5 AXISMEDIATED RECRUITMENT OF TREG89
0.10921788215637